COMPOUNDS RESISTANT TO METABOLIC DEACTIVATION AND METHODS OF USE
申请人:BAYLOR UNIVERSITY
公开号:EP1581547A2
公开(公告)日:2005-10-05
Compounds resistant to metabolic deactivation and methods of use
申请人:Kane Ronald Robert
公开号:US20080070859A1
公开(公告)日:2008-03-20
Therapeutic compounds having increased resistance to deamination and inactivation by metabolic enzymes are provided. The compounds include nucleotide analogs and nucleotide analogs, derivatized with aminal and/or thioaminal groups to prevent deamination of free amine. The compounds can be used in a variety of treatments, including treatment of neoplastic disorders, infections from fungal or fungal-like organisms, and infections from parasites.
[EN] COMPOUNDS RESISTANT TO METABOLIC DEACTIVATION AND METHODS OF USE<br/>[FR] COMPOSES RESISTANT A LA DESACTIVATION METABOLIQUE ET PROCEDES D'UTILISATION